Investing Profile

Rémi Droller

InvestorVC
Managing Partner at Kurma Partners
kurmapartners.com/en/teamParis, France
Photo of Rémi Droller, Managing Partner at Kurma Partners
Your Intro Paths to Rémi Droller

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Rémi Droller on

cb
Current Investing Position
Kurma Partners Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
14

Rémi Droller is on these Sector & Stage Rankings

Rémi Droller's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Vico Therapeutics
Series BJan 2024$59M
Series AJul 2020$31M
$90M
Co-investors: Amy Schulman (Polaris Partners), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences), Silvia Noiman (Pontifax Venture Capital)
ImCheck Therapeutics
Series CJun 2022$100M
Series BDec 2019$53M
Series AMay 2017$22M
$180M
Co-investors: Raphael Wisniewski (Andera Partners), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Florent Gros (Earlybird Venture Capital), Klaus Breiner (Pureos Bioventures), Vincent Brichard
AM Pharma
Series UnknownMar 2020$25M
Series FJul 2019$130M
Series ESep 2014$16M
Series DSep 2011$40M
$210M
Co-investors: Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion), Joël Jean-Mairet (Ysios Capital), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences), Laia Crespo (Sanofi Ventures)
Santen Pharmaceutical
Post Ipo EquitySep 2009$22M
Post Ipo EquityApr 2006$31M
Post Ipo EquitySep 2004$11M
Post Ipo EquityNov 2003$6M
Post Ipo EquityJan 2000$4M
$74M